PL1951395T3 - Sposób ilościowego oznaczania poloksamerów - Google Patents

Sposób ilościowego oznaczania poloksamerów

Info

Publication number
PL1951395T3
PL1951395T3 PL06793534T PL06793534T PL1951395T3 PL 1951395 T3 PL1951395 T3 PL 1951395T3 PL 06793534 T PL06793534 T PL 06793534T PL 06793534 T PL06793534 T PL 06793534T PL 1951395 T3 PL1951395 T3 PL 1951395T3
Authority
PL
Poland
Prior art keywords
poloxamers
quantitative determination
quantitative
determination
Prior art date
Application number
PL06793534T
Other languages
English (en)
Inventor
Mara Rossi
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of PL1951395T3 publication Critical patent/PL1951395T3/pl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
    • B01J20/28004—Sorbent size or size distribution, e.g. particle size
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
    • B01J20/28078—Pore diameter
    • B01J20/28083—Pore diameter being in the range 2-50 nm, i.e. mesopores
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
PL06793534T 2005-09-14 2006-09-14 Sposób ilościowego oznaczania poloksamerów PL1951395T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05108439 2005-09-14
US71764205P 2005-09-16 2005-09-16
PCT/EP2006/066383 WO2007031566A1 (en) 2005-09-14 2006-09-14 Method for the quantitative determination of poloxamers
EP06793534A EP1951395B1 (en) 2005-09-14 2006-09-14 Method for the quantitative determination of poloxamers

Publications (1)

Publication Number Publication Date
PL1951395T3 true PL1951395T3 (pl) 2012-08-31

Family

ID=37198996

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06793534T PL1951395T3 (pl) 2005-09-14 2006-09-14 Sposób ilościowego oznaczania poloksamerów

Country Status (12)

Country Link
US (1) US7866203B2 (pl)
EP (1) EP1951395B1 (pl)
KR (1) KR20080043301A (pl)
AU (1) AU2006290662B2 (pl)
CA (1) CA2612613A1 (pl)
CY (1) CY1112488T1 (pl)
EA (1) EA014585B1 (pl)
HK (1) HK1119614A1 (pl)
IL (1) IL190139A (pl)
NO (1) NO20081794L (pl)
PL (1) PL1951395T3 (pl)
WO (1) WO2007031566A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101343040B1 (ko) * 2010-12-28 2013-12-18 주식회사 삼양바이오팜 정제된 폴록사머 및 그의 정제방법
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN111175385B (zh) * 2018-11-12 2023-02-07 珠海润都制药股份有限公司 一种厄贝沙坦中厄贝沙坦同分异构体检验方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119740A (en) 1959-04-13 1964-01-28 Armour Pharma Process for preparing purified follicle stimulating hormone
GB8600245D0 (en) * 1986-01-07 1986-02-12 Shell Int Research Preparation of 2-arylpropionic acids
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
ES2104690T3 (es) 1989-12-22 1997-10-16 Applied Research Systems Modificaciones de la expresion de genes endogenos con un elemento regulador por medio de recombinacion homologa.
US6306421B1 (en) * 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) * 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) * 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6685940B2 (en) * 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
DK0996629T3 (da) 1997-06-25 2006-12-04 Applied Research Systems Disulfidtværbundne glycoproteinhormonanaloger, deres fremstilling og anvendelse
US6433144B1 (en) * 1999-01-12 2002-08-13 Viragen, Inc. Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
WO2001058493A1 (en) 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
US7179617B2 (en) * 2001-10-10 2007-02-20 Neose Technologies, Inc. Factor IX: remolding and glycoconjugation of Factor IX
US7226903B2 (en) * 2001-10-10 2007-06-05 Neose Technologies, Inc. Interferon beta: remodeling and glycoconjugation of interferon beta
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7157277B2 (en) * 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7265084B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7399613B2 (en) * 2001-10-10 2008-07-15 Neose Technologies, Inc. Sialic acid nucleotide sugars
US7125843B2 (en) * 2001-10-19 2006-10-24 Neose Technologies, Inc. Glycoconjugates including more than one peptide
US7265085B2 (en) * 2001-10-10 2007-09-04 Neose Technologies, Inc. Glycoconjugation methods and proteins/peptides produced by the methods
US7173003B2 (en) * 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7297511B2 (en) * 2001-10-10 2007-11-20 Neose Technologies, Inc. Interferon alpha: remodeling and glycoconjugation of interferon alpha
US7462365B2 (en) * 2002-10-17 2008-12-09 Costantino Henry R Microencapsulation and sustained release of biologically active polypeptides
JP4699991B2 (ja) 2003-04-02 2011-06-15 アレス トレーディング ソシエテ アノニム 非イオン性界面活性剤を一緒に伴うｆｓｈ及びｌｈの液体医薬組成物
ATE384735T1 (de) 2003-05-21 2008-02-15 Ares Trading Sa Verfahren zur chromatographischen analyse einer proteinlösung

Also Published As

Publication number Publication date
CY1112488T1 (el) 2015-12-09
IL190139A (en) 2011-11-30
AU2006290662B2 (en) 2010-12-23
EP1951395A1 (en) 2008-08-06
WO2007031566A1 (en) 2007-03-22
AU2006290662A1 (en) 2007-03-22
EP1951395B1 (en) 2012-02-29
HK1119614A1 (en) 2009-03-13
NO20081794L (no) 2008-04-14
EA014585B1 (ru) 2010-12-30
EA200800814A1 (ru) 2008-12-30
US20080190179A1 (en) 2008-08-14
CA2612613A1 (en) 2007-03-22
US7866203B2 (en) 2011-01-11
IL190139A0 (en) 2008-08-07
KR20080043301A (ko) 2008-05-16

Similar Documents

Publication Publication Date Title
GB0604346D0 (en) Method for the application of portable software
IL189449A0 (en) Method for enhancing the effect of particulate benefit agents
EP1864785A4 (en) SETEROLITHOGRAPHIEVERFAHREN
GB0504774D0 (en) Method
GB0503836D0 (en) Method
EP1891496A4 (en) METHOD FOR DISTRIBUTING CONTENTS
GB0504096D0 (en) Method
GB0509433D0 (en) Method
GB0504184D0 (en) Method
GB0507123D0 (en) Method
GB0508420D0 (en) Method
GB0505756D0 (en) Method
GB0502046D0 (en) Method
EP1839573A4 (en) METHOD FOR DETERMINING THE CONDITION OF HAIR
GB0509305D0 (en) Method
GB0509437D0 (en) Method
HK1119614A1 (en) Method for the quantitative determination of poloxamers
EG24870A (en) Method for deodorisation
GB0504182D0 (en) Method
GB0502065D0 (en) Assay method
GB0509956D0 (en) Method
GB0506670D0 (en) Method
GB0502360D0 (en) Method
TWI315261B (en) Method for transferring-printing
GB0511893D0 (en) Assay method